A clinical formulation indicated for Sleeping Pills. Targeting specific receptors in the central nervous system, treatment promotes a rapid transition into restful cycles for those experiencing occasional insomnia.
Developed to address difficulties falling asleep to alleviate short-term insomnia and support a healthy sleep cycle in adults experiencing nighttime restlessness.
Mechanism of Action
Zaleplon interacts with GABA receptors in the brain to increase inhibitory signals. This slows down the central nervous system, helping the patient fall asleep quickly without usually causing significant morning grogginess.
Route of Administration
Oral
Onset Time
15–30 minutes
Duration
4 hours
Contraindications
Severe liver impairment, History of complex sleep behaviors, Hypersensitivity to zaleplon
Information for Zaleplon is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
